Cogstate Limited (ASX: CGS)
Health Care · Health Care Technology · AU
AU$3.45
+4.86% today · +44.4% 1Y
Cogstate Limited (ASX: CGS) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $414.07M and employs 160 people.
Over the last twelve months the share price has gained 44.4%, trading between 1.75 and 3.50.
Tweenvest scores Cogstate Limited across four factors: quality 77/100, value 39/100, growth 70/100, dividend 21/100. Its strongest factor is quality.
CGS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $414.07M
- Revenue (TTM)
- $60.86M
- P/E
- 35.57
- EPS
- 0.07
- Dividend yield
- 1.25%
- Beta (5Y)
- 0.27
- 52-week high
- AU$3.50
- 52-week low
- AU$1.75
- Avg volume (3M)
- —
- Shares outstanding
- 171.99M
- Employees
- 160
- Next earnings
- —
About Cogstate Limited
Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations. Its comprehensive suite of cognitive services includes project and data management, scientific consulting, statistical analysis, procurement of assessment scales, rater training, and monitoring solutions. The company operates through two distinct divisions. The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases, pharmaceuticals, medical devices, or other interventions on human participants in clinical studies, primarily serving pharmaceutical and biotechnology clients. Concurrently, its Healthcare segment offers Cognigram, a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline. By June 30, 2022, Cogstate had participated in an estimated 1,800 academic research initiatives.
- ISIN
- AU000000CGS8
- Founded
- 1999
- Listed since
- Feb 12, 2004
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GPI S.p.A.BIT: GPI | $481.96M | €15.14 | +1.61% |
| Medley, Inc.TSE: 4480 | $463.79M | ¥2,430.00 | +5.33% |
| Evolent Health, Inc.NYSE: EVH | $456.76M | $4.12 | +1.86% |
| Claritev CorporationNYSE: CTEV | $417.92M | $24.19 | -1.91% |
| Yidu Tech Inc.SEHK: 2158 | $410.69M | HK$3.16 | -4.68% |
| Yarward Electronics (Shandong) Co., Ltd.SZSE: 301337 | $408.52M | CN¥26.26 | -4.02% |
| Goodwill E-Health Info Co., Ltd.SHSE: 688246 | $381.86M | CN¥18.59 | +5.09% |
| Artrya LimitedASX: AYA | $342.30M | AU$3.01 | -18.65% |
Figures last refreshed Oct 11, 2026.